|
FAM192A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.47889999988638E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.69495999999825E-05 |
| Normal-vs-Stage2 |
2.795900E-02 |
| Normal-vs-Stage3 |
4.357900E-02 |
| Normal-vs-Stage4 |
6.036800E-01 |
| Stage1-vs-Stage2 |
7.455800E-01 |
| Stage1-vs-Stage3 |
3.330000E-01 |
| Stage1-vs-Stage4 |
1.116780E-01 |
| Stage2-vs-Stage3 |
6.506600E-01 |
| Stage2-vs-Stage4 |
2.007000E-01 |
| Stage3-vs-Stage4 |
3.294600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.06880000031396E-07 |
| Normal-vs-AfricanAmerican |
4.445600E-04 |
| Normal-vs-Asian |
1.622650E-01 |
| Caucasian-vs-AfricanAmerican |
3.995800E-01 |
| Caucasian-vs-Asian |
5.219600E-01 |
| AfricanAmerican-vs-Asian |
3.063200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.04010000001598E-06 |
| Normal-vs-Female |
3.373500E-04 |
| Male-vs-Female |
7.504400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.412500E-02 |
| Normal-vs-Extreme_Weight |
3.59159999999692E-05 |
| Normal-vs-Obese |
2.159600E-04 |
| Normal-vs-Extreme_Obese |
2.109000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.782300E-02 |
| Normal_Weight-vs-Obese |
8.997800E-02 |
| Normal_Weight-vs-Extreme_Obese |
6.408200E-01 |
| Extreme_Weight-vs-Obese |
8.125800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.190400E-01 |
| Obese-vs-Extreme_Obese |
5.973000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.858600E-03 |
| Normal-vs-Age(41-60Yrs) |
5.87020000053506E-07 |
| Normal-vs-Age(61-80Yrs) |
3.73120000000116E-05 |
| Normal-vs-Age(81-100Yrs) |
8.748400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.023200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.723200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.157830E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.941000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.488340E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.332400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.42030054384179E-10 |
| Normal-VS-Type2 PRCC |
9.421600E-01 |
| Normal-VS-KIRP CIMP |
2.439800E-01 |
| Normal-VS-Unclassified PRCC |
2.982200E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.66833213910422E-12 |
| Type1 PRCC-VS-KIRP CIMP |
1.042240E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.075400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.157750E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.099600E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.048200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.607500E-02 |
| Normal-vs-N1 |
1.596150E-02 |
| Normal-vs-N2 |
2.439600E-01 |
| N0-vs-N1 |
6.065200E-01 |
| N0-vs-N2 |
1.572770E-01 |
| N1-vs-N2 |
7.352000E-02 |
|
|
